The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,065.00
Bid: 1,068.00
Ask: 1,073.00
Change: 6.00 (0.57%)
Spread: 5.00 (0.468%)
Open: 1,052.00
High: 1,075.00
Low: 1,052.00
Prev. Close: 1,059.00
DNLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Secondary Placing

13 Apr 2016 07:00

RNS Number : 0005V
Dunelm Group plc
13 April 2016
 

Dunelm Group plc

13 April 2016

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

SECONDARY PLACING OF ORDINARY SHARES IN DUNELM GROUP PLC

("DUNELM" OR "THE COMPANY")

 

Further to the previous announcement, Dunelm announces it has been advised that Will Adderley, Deputy Chairman, has sold 8.0 million shares in the Company, representing approximately 4.0 per cent of the issued share capital of Dunelm. The shares were placed at a price of 915 pence per share.

 

The shares sold and residual holdings are as follows:

 

Shares sold

Residual holding

Will Adderley

71,476

0

WA Capital Limited

7,728,524

54,161,779

The Stoneygate Trust

200,000

967,250

Total

8,000,000

55,129,029

 

WA Capital Limited is a company controlled by Will and Nadine Adderley; The Stoneygate Trust is a charity of which Will and Nadine Adderley are trustees.

 

Following these disposals, Will Adderley continues to have an interest in 55.3 million shares in the Company, which includes 172,750 shares held in the Paddocks Trust, of which he and his wife Nadine Adderley are trustees but not beneficiaries. In total, this represents 27.4 per cent of the issued share capital. The Adderley family as a whole retains a combined interest in 103.4 million shares in the Company, representing 51.2 per cent of the issued share capital.

 

The shares were sold to institutional investors in a placing managed by UBS Limited, acting as Bookrunner, and Stifel Nicolaus Europe Limited, acting as Co-Lead Manager.

 

The Company purchased 750,000 shares for transfer into treasury with the intention of re-issuing them to satisfy employee share based award obligations that arise in the future.

 

Will Adderley remains fully committed to Dunelm in his role as Deputy Chairman as well as remaining a very substantial shareholder in the Company.

 

Under the terms of the placing agreement, Will Adderley has agreed not to dispose of further shares in the Company for a period of at least six months.

 

Enquiries:

UBS Limited +44 (0)20 7567 8000

Craig Calvert

Christopher Smith

Stifel Nicolaus Europe Limited +44 (0)20 7710 7600

Eithne O'Leary

David Arch

 

MHP Communications +44 (0) 20 3128 8100

John Olsen

Simon Hockridge

 

Each of UBS Limited and and Stifel Nicolaus Europe Limited is acting on the Placing and will not be responsible to anyone other than its client for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement, or any transaction or arrangement referred to herein.

This announcement is for information purposes only and does not constitute or form part of an offer or invitation to acquire or dispose of any securities of Dunelm, or constitute a solicitation of any offer to purchase or subscribe for securities in any jurisdiction, including the United States, Canada, Australia or Japan. Dunelm's shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under the securities legislation of any state of the United States and may not be offered or sold in the United States absent registration or an exemption from registration.

Dunelm's shares may not, directly or indirectly, be offered or sold within the United States, Canada, Australia or Japan or offered or sold to a resident of Canada, Australia or Japan. No public offering of securities is being made in the United States.

This announcement is not for publication or distribution to persons in the United States of America, its territories or possessions or to any US person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). Neither this announcement nor any copy of it may be taken or transmitted into Australia, Canada or Japan or to Canadian persons or to any securities analyst or other person in any of those jurisdictions. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian or Japanese securities law. The distribution of this announcement in certain other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

This announcement and any offer of securities to which it relates are only addressed to and directed at persons who are (1) qualified investors within the meaning of directive 2003/71/ec and any relevant implementing measures (the prospectus directive) and (2) who have professional experience in matters relating to investments who fall within article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or are persons falling within article 49(2)(a) to (d) ("High Net Worth Companies, Unincorporated Associations, etc") of the Order (all such persons together being referred to as "relevant persons"). The information regarding the Placing set out in this announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWEEEFMSEEL
Date   Source Headline
23rd Mar 20187:00 amRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTotal Voting Rights
22nd Feb 20187:00 amRNSDirector/PDMR Shareholding
20th Feb 20187:00 amRNSDirectorate Change
20th Feb 20187:00 amRNSInterim Results
1st Feb 20187:00 amRNSConfirmation of appointment of Nick Wilkinson
31st Jan 20187:00 amRNSTotal Voting Rights
19th Jan 201810:37 amRNSHolding(s) in Company
19th Jan 201810:33 amRNSHolding(s) in Company
19th Jan 20187:00 amRNSDirector/PDMR Shareholding
17th Jan 201811:10 amRNSHolding(s) in Company
16th Jan 20187:00 amRNSSecond Quarter Trading Update
29th Dec 20177:00 amRNSTotal Voting Rights
21st Dec 20177:00 amRNSAppointment of Chief Executive
8th Dec 201710:13 amRNSDirector/PDMR Shareholding
21st Nov 201711:57 amRNSResult of AGM
20th Nov 20177:00 amRNSDirectorate Change
3rd Nov 20177:00 amRNSBlock listing Interim Review
3rd Nov 20177:00 amRNSBlock listing Interim Review
3rd Nov 20177:00 amRNSBlock listing Interim Review
3rd Nov 20177:00 amRNSBlock listing Interim Review
18th Oct 20177:00 amRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSAnnual Financial Report
11th Oct 20177:00 amRNSTrading Update and Capital Markets Event
2nd Oct 201711:35 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSTotal Voting Rights
25th Sep 20171:50 pmRNSHolding(s) in Company
20th Sep 20177:00 amRNSDirector/PDMR Shareholding
13th Sep 20177:00 amRNSFinal Results
30th Aug 20177:00 amRNSDirectorate Change
11th Aug 20173:14 pmRNSHolding(s) in Company
20th Jul 20174:51 pmRNSHolding(s) in Company
20th Jul 20174:51 pmRNSHolding(s) in Company
20th Jul 20174:49 pmRNSHolding(s) in Company
18th Jul 20177:00 amRNSDirector/PDMR Shareholding
13th Jul 20177:00 amRNSDirector/PDMR Shareholding
7th Jul 20177:00 amRNSYear-end Trading Update
19th Apr 20177:00 amRNSBlock listing Interim Review
19th Apr 20177:00 amRNSBlock listing Interim Review
19th Apr 20177:00 amRNSBlock listing Interim Review
19th Apr 20177:00 amRNSBlock listing Interim Review
12th Apr 20177:00 amRNSThird Quarter Trading Update
31st Mar 20177:00 amRNSTotal Voting Rights
7th Mar 201710:12 amRNSResult of General Meeting
3rd Mar 201711:44 amRNSHolding(s) in Company
28th Feb 20177:00 amRNSDirector/PDMR Shareholding
28th Feb 20177:00 amRNSTotal Voting Rights
23rd Feb 20177:00 amRNSDirector/PDMR Shareholding
13th Feb 20177:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.